Lataa...
HDL and glucose metabolism: current evidence and therapeutic potential
High-density lipoprotein (HDL) and its principal apolipoprotein A-I (ApoA-I) have now been convincingly shown to influence glucose metabolism through multiple mechanisms. The key clinically relevant observations are that both acute HDL elevation via short-term reconstituted HDL (rHDL) infusion and c...
Tallennettuna:
| Julkaisussa: | Front Pharmacol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4628107/ https://ncbi.nlm.nih.gov/pubmed/26582989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2015.00258 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|